Inventiva (IVA) Cash & Equivalents (2018 - 2025)

Inventiva's (IVA) quarterly Cash & Equivalents came in at $115.6 million in Q4 2025, up 53.1% year-on-year from $75.5 million in Q4 2024, and down 99.92% quarter-over-quarter from $138.2 billion in Q2 2025.

Inventiva (IVA) Cash & Equivalents (2018 - 2025) Analysis & Trends

Inventiva's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $115.6 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 53.1% year-over-year to $115.6 million in Q4 2025; TTM through Dec 2025 was $115.6 million, a 53.1% increase from a year earlier, with the FY2025 full-year figure at $115.6 million, up 53.1% from the prior year.
  • Cash & Equivalents slipped to $115.6 million in Q4 2025 per IVA's latest filing, from $138.2 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $138.2 billion in Q2 2025 and bottomed at $81529.5 in Q2 2022.
  • The 5-year median for Cash & Equivalents is $91.5 million (2022), against an average of $11.6 billion.
  • Across the five-year window, Cash & Equivalents plunged 99.93% in 2022 and soared 476603.23% in 2025, its largest moves.
  • Year by year, Cash & Equivalents stood at $99.0 million in 2021, then fell by 10.63% to $88.5 million in 2022, then sank by 89.08% to $9.7 million in 2023, then soared by 681.0% to $75.5 million in 2024, then jumped by 53.1% to $115.6 million in 2025.
  • Per Business Quant, the three latest IVA Cash & Equivalents figures stand at $115.6 million (Q4 2025), $138.2 billion (Q2 2025), and $75.5 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Inventiva 842.48 Mn 842.48 Mn - 115.59 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 115.59 Mn
Jun 30, 2025 138.19 Bn
Dec 31, 2024 75.50 Mn
Jun 30, 2024 28.99 Mn
Dec 31, 2023 9.67 Mn
Oct 11, 2023 12.54 Mn
Jun 30, 2023 94.45 Mn
Dec 31, 2022 88.49 Mn
Jun 30, 2022 81,529.53
Dec 31, 2021 99.01 Mn
Jun 30, 2021 112.76 Mn
Mar 31, 2021 130.04 Mn
Dec 31, 2020 126.01 Mn
Jun 30, 2020 57.58 Mn
Dec 31, 2019 39.67 Mn
Dec 31, 2018 64.71 Mn